Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

NIH 2OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 4Endocrine 2

Conditions

Thyroid Neoplasms 31Thyroid Cancer, Papillary 26Pheochromocytoma 23Adenocarcinoma, Follicular 23Adrenocortical Carcinoma 21Neuroendocrine Tumors 20Carcinoma, Medullary 17Somatostatinoma 14Insulinoma 14Thyroid Carcinoma, Anaplastic 13Pituitary Neoplasms 13Paraganglioma 13Carcinoma, Neuroendocrine 12Glucagonoma 11Carcinoma, Renal Cell 11Parathyroid Neoplasms 10Pancreatic Neoplasms 10Gastrinoma 10Carcinoma, Non-Small-Cell Lung 10Carcinoma, Hepatocellular 10Head and Neck Neoplasms 9Colonic Neoplasms 9Carcinoma, Islet Cell 9Breast Neoplasms 9Small Cell Lung Carcinoma 8Sarcoma 8Neoplasms 8Rectal Neoplasms 7Multiple Endocrine Neoplasia Type 1 7Adrenal Gland Neoplasms 7

Interventions

Thyrotropin-Releasing Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Hypothyroidism × Endocrine × Clear all
NCT01441154 2020-09-28

Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment

National Institutes of Health Clinical Center (CC)

Completed
16 enrolled
EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Hypothyroidism, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT00054756 2018-08-08

Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
96 enrolled 6 charts
EndocrineHead & Neck

Hypothyroidism, Pituitary Diseases, Pituitary Neoplasms, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡